Browse > Article
http://dx.doi.org/10.14475/kjhpc.2018.21.1.23

Life-Sustaining Procedures, Palliative Care, and Cost Trends in Dying COPD Patients in U.S. Hospitals: 2005~2014  

Kim, Sun Jung (Department of Health Administration and Management, Soonchunhyang University)
Shen, Jay (Department of Health Care Administration and Policy, University of Nevada Las Vegas)
Ko, Eunjeong (School of Social Work, San Diego State University)
Kim, Pearl (Department of Health Care Administration and Policy, University of Nevada Las Vegas)
Lee, Yong-Jae (Department of Family Medicine, Yonsei University College of Medicine)
Lee, Jae Hoon (Department of Family Medicine, University of Nevada Las Vegas School of Medicine)
Liu, Xibei (Department of Medicine, University of Arizona College of Medicine)
Ukken, Johnson (University of Nevada Reno School of Medicine)
Kioka, Mutsumi (Department of Internal Medicine, University of Nevada Las Vegas School of Medicine)
Yoo, Ji Won (Department of Internal Medicine, University of Nevada Las Vegas School of Medicine)
Publication Information
Journal of Hospice and Palliative Care / v.21, no.1, 2018 , pp. 23-32 More about this Journal
Abstract
Purpose: Little is known regarding the extent to which dying patients with chronic obstructive pulmonary disease (COPD) receive life-sustaining procedures and palliative care in U.S. hospitals. We examine hospital cost trends and the impact of palliative care utilization on the use of life-sustaining procedures in this population. Methods: Retrospective nationwide cohort analysis was performed using National Inpatient Sample (NIS) data from 2005 and 2014. We examined the receipt of both palliative care and intensive medical procedures, defined as systemic procedures, pulmonary procedures, or surgeries using the International Classification of Diseases, 9th revision (ICD-9-CM). Results: We used compound annual growth rates (CAGR) to determine temporal trends and multilevel multivariate regressions to identify factors associated with hospital cost. Among 77,394,755 hospitalizations, 79,314 patients were examined. The CAGR of hospital cost was 5.83% (P<0.001). The CAGRs of systemic procedures and palliative care were 5.98% and 19.89% respectively (each P<0.001). Systemic procedures, pulmonary procedures, and surgeries were associated with increased hospital cost by 59.04%, 72.00%, 55.26%, respectively (each P<0.001). Palliative care was associated with decreased hospital cost by 28.71% (P<0.001). Conclusion: The volume of systemic procedures is the biggest driver of cost increase although there is a cost-saving effect from greater palliative care utilization.
Keywords
Chronic obstructive pulmonary disease; Costs and cost analysis; Health policy; Palliative care; Interrupted time series analysis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Teno JM, Gozalo PL, Mitchell SL, Kuo S, Rhodes RL, Bynum JP, et al. Does feeding tube insertion and its timing improve survival? J Am Geriatr Soc 2012;60:1918-21.   DOI
2 Barnato AE, Cohen ED, Mistovich KA, Chang CC. Hospital end-of-life treatment intensity among cancer and non-cancer cohorts. J Pain Symptom Manage 2015;49:521-9.   DOI
3 Horton JR, Morrison RS, Capezuti E, Hill J, Lee EJ, Kelley AS. Impact of inpatient palliative care on treatment intensity for patients with serious illness. J Palliat Med 2016;19:936-42.   DOI
4 Yaqoob ZJ, Al-Kindi SG, Zein JG. Trends and disparities in hospice use among patients dying of COPD in the United States. Chest 2017;151: 1183-4.   DOI
5 Lopez Bernal J, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol 2017;46:348-55.
6 Selecky PA, Eliasson CA, Hall RI, Schneider RF, Varkey B, McCaffree DR, et al. Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest 2005;128:3599-610.   DOI
7 Knauft E, Nielsen EL, Engelberg RA, Patrick DL, Curtis JR. Barriers and facilitators to end-of-life care communication for patients with COPD. Chest 2005;127:2188-96.   DOI
8 Center for Medicare and Medicaid Services. Final rule policies for ACP delineated in the CY 2016 PFS final rule (80 Fed. Reg. 70955 through 70959) [Internet]. Baltimore, MD: Center for Medicare and Medicaid Services; 2016 [cited 2017 Oct 17]. Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/PFS-Federal-Regulation-Notices.html.
9 Kaiser Family Foundation. Health status of the Medicare population. A primer on Medicare [Internet]. Menlo Park, CA: Kaiser Family Foundation; 2015 [cited 2017 Oct 17]. Available from: http://files.kff.org/attachment/report-a-primer-on-medicare-key-facts-about-themedicare-program-and-the-people-it-covers.
10 NIHCM Foundation. Health care's big spenders: the characteristics behind the curve [Internet]. Washington, DC: National Institute for Health Care Management Foundation; 2017 [cited 2017 Oct 17]. Available from: http://www.NIHCM.org.
11 Barnato AE, Chang CH, Farrell MH, Lave JR, Roberts MS, Angus DC. Is survival better at hospitals with higher "end-of-life" treatment intensity? Med Care 2010;48:125-32.   DOI
12 Ornstein KA, Aldridge MD, Garrido MM, Gorges R, Bollens-Lund E, Siu AL, et al. The use of life-sustaining procedures in the last month is associated with more depressive symptoms in surviving spouses. J Pain Symptom Manage 2017;53:178-87.   DOI
13 Tschirhart EC, Du Q, Kelley AS. Factors influencing the use of intensive procedures at the end of life. J Am Geriatr Soc 2014;62:2088-94.   DOI
14 Claessens MT, Lynn J, Zhong Z, Desbiens NA, Phillips RS, Wu AW, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc 2000;48(5 Suppl):S146-53.   DOI
15 Lilly CM, Swami S, Liu X, Riker RR, Badawi O. Five year trends of critical care practice and outcomes. Chest 2017;152:723-35.   DOI
16 Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: final data for 2014. Natl Vital Stat Rep 2016;65:1-122.
17 Shin J, Park HY, Lee J. Hospice and palliative care in chronic obstructive pulmonary disease. Korean J Hosp Palliat Care 2017;20:81-92.   DOI
18 U.S. Bureau of Labor Statistics. Consumer price index, US average medical care from 2005 to 2014 [Internet]. Washington, DC: U.S. Bureau of Labor Statistics; 2017 [cited 2017 Oct 17]. Available from: http://www.bls/gov/cpi.
19 Dzingina MD, Reilly CC, Bausewein C, Jolley CJ, Moxham J, McCrone P, et al. Variations in the cost of formal and informal health care for patients with advanced chronic disease and refractory breathlessness: A cross-sectional secondary analysis. Palliat Med 2017;31:369-77.   DOI
20 Weingaertner V, Scheve C, Gerdes V, Schwarz-Eywill M, Prenzel R, Bausewein C, et al. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study. J Pain Symptom Manage 2014;48:569-81.   DOI
21 Habraken JM, ter Riet G, Gore JM, Greenstone MA, Weersink EJ, Bindels PJ, et al. Health-related quality of life in end-stage COPD and lung cancer patients. J Pain Symptom Manage 2009;37:973-81.   DOI
22 Wachterman MW, Pilver C, Smith D, Ersek M, Lipsitz SR, Keating NL. Quality of end-of-life care provided to patients with different serious illnesses. JAMA Intern Med 2016;176:1095-102.   DOI
23 Aslakson RA, Curtis JR, Nelson JE. The changing role of palliative care in the ICU. Crit Care Med 2014;42:2418-28.   DOI
24 Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-smallcell lung cancer. New Engl J Med 2010;363:733-42.   DOI
25 May P, Garrido MM, Cassel JB, Kelley AS, Meier DE, Normand C, et al. Cost analysis of a prospective multi-site cohort study of palliative care consultation teams for adults with advanced cancer: Where do cost-savings come from? Palliat Med 2017;31:378-86.   DOI
26 Rush B, Hertz P, Bond A, McDermid RC, Celi LA. Use of palliative care in patients with end-stage COPD and receiving home oxygen: National trends and barriers to care in the United States. Chest 2017;151:41-6.   DOI
27 Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000;55:1000-6.   DOI
28 Brumley R, Enguidanos S, Jamison P, Seitz R, Morgenstern N, Saito S, et al. Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care. J Am Geriatr Soc 2007;55:993-1000.   DOI
29 May P, Garrido MM, Cassel JB, Kelley AS, Meier DE, Normand C, et al. Palliative care teams' cost-saving effect is larger for cancer patients with higher numbers of comorbidities. Health Aff (Millwood) 2016;35:44-53.   DOI
30 Liu X, Dawod Y, Wonnaparhown A, Shafi A, Doo L, Yoo JW, et al. Effects of hospital palliative care on health, length of stay, and in-hospital mortality across intensive and non-intensive-care units: A systematic review and metaanalysis. Palliat Support Care 2017;15:741-52.   DOI
31 Bausewein C, Booth S, Gysels M, Kuhnbach R, Haberland B, Higginson IJ. Individual breathlessness trajectories do not match summary trajectories in advanced cancer and chronic obstructive pulmonary disease: results from a longitudinal study. Palliat Med 2010;24:777-86.   DOI
32 Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 2001;15:287-95.   DOI
33 Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J 2008;32:796-803.   DOI
34 Vermylen JH, Szmuilowicz E, Kalhan R. Palliative care in COPD: an unmet area for quality improvement. Int J Chron Obstruct Pulmon Dis 2015;10:1543-51.
35 Au DH, Udris EM, Fihn SD, McDonell MB, Curtis JR. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med 2006;166:326-31.   DOI
36 Schroedl CJ, Yount SE, Szmuilowicz E, Hutchison PJ, Rosenberg SR, Kalhan R. A qualitative study of unmet healthcare needs in chronic obstructive pulmonary disease. A potential role for specialist palliative care? Ann Am Thorac Soc 2014;11:1433-8.   DOI
37 Brown CE, Jecker NS, Curtis JR. Inadequate palliative care in chronic lung disease. an issue of health care inequality. Ann Am Thorac Soc 2016;13:311-6.   DOI
38 Brown CE, Engelberg RA, Nielsen EL, Curtis JR. Palliative care for patients dying in the intensive care unit with chronic lung disease compared with metastatic cancer. Ann Am Thorac Soc 2016;13:684-9.   DOI
39 Teno JM, Gozalo PL, Bynum JP, Leland NE, Miller SC, Morden NE, et al. Change in end-of-life care for Medicare beneficiaries: Site of death, place of care, and health care transitions in 2000, 2005, and 2009. JAMA 2013;309:470-7.   DOI
40 Meier DE, Back AL, Berman A, Block SD, Corrigan JM, Morrison RS. A national strategy for palliative care. Health Aff (Millwood) 2017;36: 1265-73.   DOI
41 von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453-7.   DOI
42 Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project [Internet]. Rockville, MD: Agency for Healthcare Research and Quality; 2017 [cited 2017 Oct 17]. Available from: http://www.hcup-us.ahrq.gov/db/quality.jsp.
43 Cimasi RJ. Healthcare valuation. Chapter 8. Valuation approaches and methods. Hoboken, New Jersey:Wiley;2014. p. 39-44. (The series in Wiley finance series; vol. 1).
44 Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. 2014 Introduction to the NIS [Internet]. Rockville, MD: Agency for Healthcare Research and Quality; 2017 [cited 2017 Oct 17]. Available from: http://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2014.jsp.
45 Martin AB, Hartman M, Benson J, Catlin A; National Health Expenditure Accounts Team. Nation health spending in 2014; faster growth driven by coverage expansion and prescription drug spending. Health Aff (Millwood) 2016;35:150-60.   DOI
46 Moses H 3rd, Matheson DH, Dorsey ER, George BP, Sadoff D, Yoshimura S. The anatomy of health care in the United States. JAMA 2013; 310:1947-63.   DOI
47 Rao JNK, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics 1992;48:577-85.   DOI
48 Houchens R, Chu B, Steiner C. HCUP methods series. Report #2014-04 [Internet]. Rockville, MD: Agency for Healthcare Research and Quality; 2017 [cited 2017 Oct 18]. Available from: http://www.hcup-us.ahrq.gov/reports/methods/jsp.
49 Casanova C, de Torres JP, Aguirre-Jaime A, Pinto-Plata V, Marin JM, Cordoba E, et al. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med 2011;184:1015-21.   DOI
50 Holst LB, Petersen MW, Hasse N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomized trials with meta-analysis and trial sequential analysis. BMJ 2015;350:h1354.   DOI